STOCK TITAN

Gladstone Commercial Executes 10-Year Lease at Office / R&D Property in New Albany, OH

(Neutral)
(Neutral)
Tags

Gladstone Commercial (Nasdaq: GOOD) executed a new 10-year, 5-month lease with Ohio Life Sciences for 34,361 square feet at its 86,301-square-foot office/R&D property in New Albany, Ohio.

The deal brings the building to 100% occupancy and supports Ohio Life Sciences’ up-to-$30 million biomanufacturing workforce initiative and training center.

Loading...
Loading translation...

Positive

  • 10-year, 5-month lease signed with Ohio Life Sciences
  • 34,361 square feet leased in New Albany, Ohio property
  • Office/R&D building reaches 100% occupancy after new lease

Negative

  • None.

News Market Reaction – GOOD

+1.53%
+1.53% Session close to close

In the Jul 2 session, GOOD gained 1.53%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement secures a 10-year, 5-month lease that brings the New Albany office/R&D asset to 10...
Analysis

This announcement secures a 10-year, 5-month lease that brings the New Albany office/R&D asset to 100% occupancy, reinforcing GOOD’s leasing track record alongside recent industrial acquisitions and ongoing insider net buying, though quarterly earnings variability remains a key watchpoint.

Key Figures

Lease term: 10-year, 5-month Leased space: 34,361 square feet Building size: 86,301 square feet +3 more
6 metrics
Lease term 10-year, 5-month New lease with Ohio Life Sciences Association
Leased space 34,361 square feet Portion of New Albany, OH office / R&D building
Building size 86,301 square feet Total size of New Albany, OH office / R&D property
Occupancy 100% occupancy Resulting occupancy of the New Albany building
Life sciences establishments nearly 5,000 Ohio life sciences establishments represented by Ohio Life Sciences
Workforce initiative size $30 million Ohio Life Sciences biomanufacturing workforce initiative

Historical Context

5 past events · Latest: Jun 02 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jun 02 Board change Neutral +0.8% Election of new director expanding board and committee participation.
May 21 Property acquisition Positive +0.8% Acquisition of fully leased industrial property funded with internal cash.
May 07 Quarterly update Neutral +0.9% Mixed 1Q26 metrics with steady portfolio fundamentals and coverage.
May 05 Earnings report Neutral -3.8% Q1 2026 results with lower core FFO but higher net income versus prior quarter.
May 04 Earnings call info Neutral -0.5% Announcement of timing and access details for Q1 2026 earnings call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

GOOD has generally seen modestly positive reactions to operational and corporate updates, with one notable negative move following quarterly earnings.

Key Terms

biomanufacturing, r&d, accretive capital
3 terms
biomanufacturing medical
"prepare Ohio's workforce for careers in pharmaceutical biomanufacturing through the new"
Making medicines, vaccines and other products using living cells or biological systems instead of purely chemical processes; it is the industrial-scale “cooking” of biological ingredients into finished medical products. Investors care because biomanufacturing determines how quickly and cheaply a company can deliver therapies, meet demand, pass regulatory checks and protect earnings—like a bakery’s ovens and recipes deciding how much bread it can sell and at what cost.
r&d technical
"34,361 square feet of its 86,301 square foot office / R&D building located"
Research and development (R&D) is the work a company does to discover new products, improve existing ones, or develop better ways of making things — like a kitchen testing recipes to create a hit dish. For investors it matters because R&D is where future sales and competitive advantages are born, but it also uses cash and carries risk, so R&D spending and outcomes signal a company’s growth potential and uncertainty.
accretive capital financial
"example of our strategic deployment of accretive capital into our portfolio"
Accretive capital is money a company raises or receives that increases the value per share for existing investors — for example, financing or an investment that boosts profits or cash flow more than it dilutes ownership. Think of it like adding a profitable new room to a house: the home’s overall value grows faster than the cost of the addition. Investors watch for accretive capital because it can lift earnings per share and support higher stock prices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MCLEAN, VA / ACCESS Newswire / July 1, 2026 / Gladstone Commercial Corporation (Nasdaq:GOOD) ("Gladstone Commercial") announced that it has executed a 10-year, 5-month lease with the Ohio Life Sciences Association ("Ohio Life Sciences") for 34,361 square feet of its 86,301 square foot office / R&D building located in New Albany, Ohio. This brings the building to 100% occupancy.

Ohio Life Sciences is a statewide business association representing the interests of Ohio's nearly 5,000 life sciences establishments with the mission to grow the life sciences ecosystem. The lease will enable Ohio Life Sciences to deliver on an up-to-$30 million biomanufacturing workforce initiative announced in September 2025. The initiative includes the development of a world-class training center featuring simulated laboratories and clean rooms to provide hands-on skills training.

"We are excited to welcome Ohio Life Sciences and to support its efforts to prepare Ohio's workforce for careers in pharmaceutical biomanufacturing through the new state-of-the-art Ohio Life Sciences Training Center," said Judy Carter, Senior Vice President, who leads asset management within the Midwest Region for Gladstone Commercial. "I would also like to thank Weston Devore of CBRE for his efforts in guiding this lease to completion."

"Adding Ohio Life Sciences brings this office property to 100% occupancy and is another example of our strategic deployment of accretive capital into our portfolio," added Ryan Carter, Executive Vice President for the Midwest and Western Regions for Gladstone Commercial.

About Gladstone Commercial Corporation (Nasdaq: GOOD)

Gladstone Commercial is a real estate investment trust focused on acquiring, owning and operating net leased industrial and office properties across the United States. As of March 31, 2026, Gladstone Commercial's real estate portfolio consisted of 151 properties located in 27 states, totaling approximately 17.7 million square feet. For additional information, please visit www.gladstonecommercial.com.

For Broker Submittals: For Asset Management Matters:

Ryan Carter

Judy Carter

Executive Vice President

Senior Vice President

(571) 451-0019

(703) 462-1024

Ryan.Carter@gladstone.com

Judy.Carter@gladstone.com

Investor or Media Inquiries:

Buzz Cooper

Catherine Gerkis

CEO & President

Director of Investor Relations/ESG

(703) 287-5815

(703) 287-5846

Buzz.Cooper@gladstone.com

Catherine.Gerkis@gladstone.com

All statements contained in this press release, other than historical facts, may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements involve inherent risks and uncertainties as they relate to expectations, beliefs, projections, future plans and strategies, anticipated events, or trends concerning matters that are not historical facts and may ultimately prove to be incorrect or false. Forward-looking statements include information about possible or assumed future events, including, without limitation, those relating to the discussion and analysis of Gladstone Commercial's business, financial condition, results of operations, and our strategic plans and objectives. Words such as "may," "might," "believe," "will," "anticipate," "future," "could," "growth," "plan," "intend," "expect," "should," "would," "if," "seek," "possible," "potential," "likely" and variations of these words and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements contain these words. Forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from those included within or contemplated by such statements, including, but not limited to, the description of risks and uncertainties in "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" of the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC on February 18, 2026, and certain other filings we make with the SEC. Gladstone Commercial cautions readers not to place undue reliance on any such forward-looking statements which speak only as of the date made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

For further information: Gladstone Commercial Corporation, (703) 287-5893

For Investor Relations inquiries related to any of the monthly dividend paying Gladstone funds, please visit www.gladstonecompanies.com.

SOURCE: Gladstone Commercial Corporation



View the original press release on ACCESS Newswire

FAQ

What lease did Gladstone Commercial (GOOD) announce on July 1, 2026?

Gladstone Commercial announced a 10-year, 5-month lease with Ohio Life Sciences for 34,361 square feet in New Albany, Ohio. According to Gladstone Commercial, this agreement is at its 86,301-square-foot office/R&D property and marks full occupancy of the building.

How much space did Ohio Life Sciences lease from Gladstone Commercial (GOOD) in New Albany, Ohio?

Ohio Life Sciences leased 34,361 square feet from Gladstone Commercial at its New Albany, Ohio office/R&D building. According to Gladstone Commercial, this space is part of an 86,301-square-foot property that is now fully occupied following the execution of the long-term lease.

Did the new Ohio Life Sciences lease bring Gladstone Commercial’s New Albany property to 100% occupancy?

Yes, the Ohio Life Sciences lease brought the New Albany office/R&D property to 100% occupancy. According to Gladstone Commercial, leasing 34,361 square feet in the 86,301-square-foot building completed the remaining vacancy at the Ohio asset.

Who is Ohio Life Sciences, the new tenant in Gladstone Commercial’s (GOOD) New Albany building?

Ohio Life Sciences is a statewide business association representing nearly 5,000 life sciences establishments in Ohio. According to Gladstone Commercial, the group will support an up-to-$30 million biomanufacturing workforce initiative and develop a training center at the leased facility.

How does the Gladstone Commercial (GOOD) lease support Ohio Life Sciences’ workforce initiative?

The lease provides space for Ohio Life Sciences to advance an up-to-$30 million biomanufacturing workforce initiative. According to Gladstone Commercial, plans include a training center with simulated laboratories and clean rooms to deliver hands-on skills training for pharmaceutical biomanufacturing careers.